In this segment, panelists address coverage strategies health plans may utilize to finance patient access to the combination treatment.
ICYMI: Highlights From Asembia’s AXS25 Summit
AI revolutionizes pharmacy by automating workloads, enhancing patient care, and navigating drug pricing challenges amid evolving federal policies.
Read More
2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA
Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.
Listen
Top 5 Gated Content for 2025
Explore the evolving landscape of drug pricing, reproductive rights, and health policy in 2025, featuring insights on SC pembrolizumab and RFK Jr's hearings.
From Niche to Mainstream: Transforming Physical Therapy by Refining Remote Therapeutic Monitoring
Medbridge is working to refine remote therapeutic monitoring, or RTM, to transform physical therapy and enhance patient care.
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
Trump secures new pricing deals with 9 drugmakers, advancing his effort to align US drug costs with Europe and expand direct-to-consumer purchasing.
Pharma Leaders Stress Policy, Value-Based Care, and Collaboration as Key to Improving Drug Access
Industry leaders discuss how policy, pricing, and innovation will shape the future of oncology care and patient access.